| 2024 | New-onset atrial fibrillation in seropositive rheumatoid arthritis: association with disease-modifying anti-rheumatic drugs treatment | RHEUMATOLOGY |
| 2024 | Circulating cold-inducible RNA-binding protein levels in microscopic polyangiitis and granulomatosis with polyangiitis : Correlation with disease activity | ZEITSCHRIFT FUR RHEUMATOLOGIE |
| 2024 | Birmingham vasculitis activity score and the short form 36-item health survey predict current depressive disorders in patients with antineutrophil cytoplasmic antibody-associated vasculitis during the SARS-CoV-2 pandemic
| ZEITSCHRIFT FUR RHEUMATOLOGIE |
| 2024 | Clinical association of health-related quality of life and mortality in an antineutrophil cytoplasmic antibody-associated vasculitis cohort | SEMINARS IN ARTHRITIS AND RHEUMATISM |
| 2024 | Renal prognosis in patients with new-onset microscopic polyangiitis and granulomatosis with polyangiitis requiring dialysis and potential predictor of renal function recovery
| Journal of Rheumatic Diseases |
| 2024 | Antineutrophil cytoplasmic antibody-associated vasculitis classification by cluster analysis based on clinical phenotypes: a single-center retrospective cohort study | CLINICAL RHEUMATOLOGY |
| 2024 | Association Between Decreased Renal Function and Pulmonary Function Decline in Community-dwelling Adults
| IN VIVO |
| 2023 | Clinical implications of peripheral eosinophil count at diagnosis in patients newly diagnosed with microscopic polyangiitis and granulomatosis with polyangiitis
| ARTHRITIS RESEARCH & THERAPY |
| 2023 | IL-6 Receptor Expression on the Surface of T Cells and Serum Soluble IL-6 Receptor Levels in Patients with Microscopic Polyangiitis and Granulomatosis with Polyangiitis
| JOURNAL OF CLINICAL MEDICINE |
| 2023 | Soluble triggering receptor expressed on myeloid cell-1 reflects the cross-sectional activity of microscopic polyangiitis and granulomatosis with polyangiitis
| HELIYON |
| 2023 | Vasculitis Activity-Predicting Ability of IL-12 Family Cytokines in Patients with Microscopic Polyangiitis and Granulomatosis with Polyangiitis
| YONSEI MEDICAL JOURNAL |
| 2023 | A new index for distinguishing hypereosinophilic syndrome and antineutrophil cytoplasmic antibody-negative eosinophilic granulomatosis with polyangiitis
| ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY |
| 2023 | Renal histopathological predictors of end-stage kidney disease in ANCA-associated vasculitis with glomerulonephritis: a single-centre study in Korea
| SCIENTIFIC REPORTS |
| 2023 | Association between computed tomography-assessed sarcopenia and mortality in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis | INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES |
| 2023 | Cancers and cardiovascular diseases in patients with seropositive rheumatoid arthritis treated with JAK inhibitors, biologics and conventional synthetic DMARDs
| CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
| 2023 | Incidence of septic arthritis in patients with ankylosing spondylitis and seropositive rheumatoid arthritis following TNF inhibitor therapy | RHEUMATOLOGY |
| 2023 | Acute Brain Infarction in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Korean Single-Center Study | JCR-JOURNAL OF CLINICAL RHEUMATOLOGY |
| 2023 | A prognostic immune nutritional index can predict all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis
| THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE |
| 2023 | Risk of cancer, tuberculosis and serious infections in patients with ankylosing spondylitis, psoriatic arthritis and psoriasis treated with IL-17 and TNF-α inhibitors: a nationwide nested case-control analysis
| CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
| 2023 | Total Globulin Fraction at Diagnosis Could Forecast All-Cause Mortality during the Disease Course in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| JOURNAL OF CLINICAL MEDICINE |
| 2023 | Predictive potential of albumin-alkaline phosphatase ratio for cerebrovascular accident in patients with antineutrophil cytoplasmic antibody-associated vasculitis | ANNALS OF CLINICAL BIOCHEMISTRY |
| 2023 | New index using triglyceride glucose-body mass index for predicting mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis
| FRONTIERS IN MEDICINE |
| 2023 | Soluble Tyro-3 and Axl may reflect the current activity and renal involvement in patients with microscopic polyangiitis and granulomatosis with polyangiitis
| CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
| 2023 | Serum soluble interleukin-7 receptor alpha levels are negatively correlated with the simultaneous activity of antineutrophil cytoplasmic antibody-associated vasculitis
| CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
| 2023 | Application of the 2022 ACR/EULAR criteria for microscopic polyangiitis to patients with previously diagnosed microscopic polyangiitis
| CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
| 2023 | Management of antineutrophil cytoplasmic antibody-associated vasculitis: a review of recent guidelines
| Journal of Rheumatic Diseases |
| 2023 | Reclassification of previously diagnosed GPA patients using the 2022 ACR/EULAR classification criteria | RHEUMATOLOGY |
| 2023 | Positive faecal immunochemical test predicts the onset of inflammatory bowel disease: A nationwide, propensity score-matched study
| FRONTIERS IN IMMUNOLOGY |
| 2023 | The Reclassification of Patients With Previously Diagnosed Eosinophilic Granulomatosis With Polyangiitis Based on the 2022 ACR/EULAR Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis | JOURNAL OF RHEUMATOLOGY |
| 2023 | Cancer-associated vasculitides: a single-centre case series | CLINICAL RHEUMATOLOGY |
| 2022 | Soluble immune checkpoint molecules in patients with antineutrophil cytoplasmic antibody-associated vasculitis
| SCIENTIFIC REPORTS |
| 2022 | Clinical impact of proteinase 3-antineutrophil cytoplasmic antibody positivity in eosinophilic granulomatosis with polyangiitis
| KOREAN JOURNAL OF INTERNAL MEDICINE |
| 2022 | Interferon-gamma Release Assay Results Are Reliable for Screening for Latent Tuberculosis in Antineutrophil Cytoplasmic Antibody-associated Vasculitis
| IN VIVO |
| 2022 | BVAS version 3 and BVAS/GPA: standing on the same line? | CLINICAL RHEUMATOLOGY |
| 2022 | Clinical impact of antineutrophil cytoplasmic antibody positivity on the occurrence of interstitial lung disease in patients with polymyositis/dermatomyositis
| ANNALS OF PALLIATIVE MEDICINE |
| 2022 | Assessment of disease activity in patients with rheumatoid arthritis using plasma tumour M2-pyruvate kinase test
| FRONTIERS IN IMMUNOLOGY |
| 2022 | Serum glycated albumin as a predictive biomarker for renal involvement of antineutrophil cytoplasmic antibody-associated vasculitis in non-diabetic patients
| BMC NEPHROLOGY |
| 2022 | Nutrition Risk Index Score at Diagnosis Can Effectively Predict Poor Prognosis in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis | JOURNAL OF RENAL NUTRITION |
| 2022 | Modified Body Mass Index at Diagnosis is a Useful Predictor of Mortality in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis
| Journal of Rheumatic Diseases |
| 2022 | Predicting the depressive status using empirical dietary inflammatory index in patients with antineutrophil cytoplasmic antibody-associated vasculitis
| JOURNAL OF CLINICAL LABORATORY ANALYSIS |
| 2022 | A positive faecal immunochemical test result and its association with the incidence of rheumatoid arthritis, systemic lupus erythematosus, and psoriatic arthritis: an analysis of one-million national colorectal cancer screening programme results
| BMC MEDICINE |
| 2022 | Secular Trends of Incidence, Prevalence, and Healthcare Economic Burden in ANCA-Associated Vasculitis: An Analysis of the 2002-2018 South Korea National Health Insurance Database
| FRONTIERS IN MEDICINE |
| 2022 | Serum albumin, prealbumin, and ischemia-modified albumin levels in patients with ANCA-associated vasculitis: A prospective cohort study
| PLOS ONE |
| 2022 | Fatty Liver Index Independently Predicts All-Cause Mortality in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis but No Substantial Liver Disease
| FRONTIERS IN CARDIOVASCULAR MEDICINE |
| 2022 | Triglyceride and Glucose Index Predicts Acute Coronary Syndrome in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| DIAGNOSTICS |
| 2022 | Association of serum hepatoma-derived growth factor levels with disease activity in rheumatoid arthritis: A pilot study
| JOURNAL OF CLINICAL LABORATORY ANALYSIS |
| 2022 | Serum galectin-9 could be a potential biomarker in assessing the disease activity of antineutrophil cytoplasmic antibody-associated vasculitis
| CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
| 2022 | Effect of numbers of metabolic syndrome components on mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis with metabolic syndrome
| CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
| 2022 | New body mass index for predicting prognosis in patients with antineutrophil cytoplasmic antibody-associated vasculitis
| JOURNAL OF CLINICAL LABORATORY ANALYSIS |
| 2022 | Incidence and Patterns of Interstitial Lung Disease and Their Clinical Impact on Mortality in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Korean Single-Centre Observational Study
| JOURNAL OF IMMUNOLOGY RESEARCH |
http://orcid.org/0000-0002-9002-9880
